Detalhe da pesquisa
1.
Chelation efficacy and erythroid response during deferasirox treatment in patients with myeloproliferative neoplasms in fibrotic phase.
Eur J Haematol
; 96(6): 643-9, 2016 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-26277477
2.
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Clin Cancer Res
; 12(24): 7374-9, 2006 Dec 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17189410
3.
Fludarabine plus mitoxantrone with and without rituximab versus CHOP with and without rituximab as front-line treatment for patients with follicular lymphoma.
J Clin Oncol
; 22(13): 2654-61, 2004 Jul 01.
Artigo
Inglês
| MEDLINE | ID: mdl-15159414
4.
Azacytidine for the treatment of retrospective analysis from the Gruppo Laziale for the study of Ph-negative MPN.
Leuk Res
; 39(8): 801-4, 2015 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-26065981